VeriChip Corporation and RECEPTORS LLC to unveil development
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today they will host an event for the medical, patient and investor communities on October 22, 2009, in New York to unveil details of their virus triage detection system for the H1N1 virus and Phase II development of an in vivo glucose-sensing RFID microchip.
Evotec, a pharmaceutical company, has entered into a multiple target drug discovery collaboration with Shionogi & Co to identify small molecule modulators of various protein-protein interaction targets.